CR
Highly rated in
1
conditions
Highly rated in
1
conditions
Check Dr. Colin M. Roberts' experience treating your condition:
About Dr. Colin M. Roberts

Colin Roberts is a Neurologist and a Child Neurologist in Portland, Oregon. Roberts has been practicing medicine for over 27 years and is highly rated in 1 condition, according to our data. His top areas of expertise are Lennox-Gastaut Syndrome, Epilepsy, Seizures, and Myoclonus Epilepsy Partial Seizure. He is licensed to treat patients in Oregon. Roberts is currently accepting new patients.

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Colin M. Roberts it is best to call his office and ask if your insurance is accepted.


Dr. Colin M. Roberts accepts the following insurance:

  •  Ambetter
  •  PacificSource
  •  Regence
  •  Moda Health
  •  Prominence Health
  •  BridgeSpan

Call to see if your plan is accepted.
Locations
700 Sw Campus Dr, Portland, OR 97239
Background & Education
Graduate Institution
Jefferson Medical College Of Thomas Jefferson University, 1995
Specialties
Neurology
Child Neurology
Pediatrics
Licenses
Neurology with Special Qualifications in Neurology in OR
Hospital Affiliations
Asante Rogue Regional Medical Center
OHSU Hospital - Portland
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


16 Total Publications

Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6.
Summary: Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors